Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Seierstad

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|November 19, 2021
Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building BlocksMark Seierstad, Mark S Tichenor, Renee L DesJarlais, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative ModulatorsBrad M Savall, Dongpei Wu, Devin M Swanson, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptorDevin M Swanson, Victoria D Wong, Jill A Jablonowski, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophoreJohn M Keith, Leslie A Gomez, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William Jones, Joan M Pierce, et al.
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and PrimateJohn M Keith, Rich Apodaca, Mark Tichenor, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|November 19, 2021
Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building BlocksMark Seierstad, Mark S Tichenor, Renee L DesJarlais, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative ModulatorsBrad M Savall, Dongpei Wu, Devin M Swanson, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2011
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y₂ receptorDevin M Swanson, Victoria D Wong, Jill A Jablonowski, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophoreJohn M Keith, Leslie A Gomez, Michael A Letavic, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2008
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolaseJohn M Keith, Richard Apodaca, Wei Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|August 14, 2020
Heteroarylureas with fused bicyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William Jones, Joan M Pierce, et al.
The Journal of Biological Chemistry|July 4, 2007
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterizationChester Kuei, Steven Sutton, Pascal Bonaventure, et al.
ACS Medicinal Chemistry Letters|December 30, 2015
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279John M Keith, William M Jones, Mark Tichenor, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and PrimateJohn M Keith, Rich Apodaca, Mark Tichenor, et al.
Pageof 3